J Clin Invest. 2011;121(2):628-639. https://doi.org/10.1172/JCI43758. RHO family proteins are important for the function of inflammatory cells. They are modified with a 20-carbon geranylgeranyl lipid in a process catalyzed by protein geranylgeranyltransferase type I (GGTase-I). Geranylgeranylation is viewed as essential for the membrane targeting and activity of RHO proteins. Consequently, inhibiting GGTase-I to interfere with RHO protein activity has been proposed as a strategy to treat inflammatory disorders. However, here we show that mice lacking GGTase-I in macrophages develop severe joint inflammation resembling erosive rheumatoid arthritis. The disease was initiated by the GGTase-I-deficient macrophages and was transplantable and reversible in bone marrow transplantation experiments. The cells accumulated high levels of active GTPbound RAC1, CDC42, and RHOA, and RAC1 remained associated with the plasma membrane. Moreover, GGTase-I deficiency activated p38 and NF-kB and increased the production of proinflammatory cytokines. The results challenge the view that geranylgeranylation is essential for the activity and localization of RHO family proteins and suggest that reduced geranylgeranylation in macrophages can initiate erosive arthritis.
Introduction
Small GTPases of RHO family proteins such as RAC1, RHOA, and CDC42 regulate the actin cytoskeleton during cell migration and phagocytosis and participate in intracellular signaling pathways (1, 2) . RHO family proteins are modified with a 20-carbon geranylgeranyl lipid on the cysteine residue of a carboxyterminal CAAX motif, a modification catalyzed by protein geranylgeranyltransferase type I (GGTase-I) (3) . Other CAAX proteins, such as RAS and prelamin A, are modified with a 15-carbon farnesyl lipid by farnesyltransferase (FTase). Farnesylation and geranylgeranylation are collectively called prenylation. GGTase-I and FTase are cytosolic enzymes that share a common α subunit but have distinct β subunits that dictate substrate specificity (3) .
Geranylgeranylation facilitates membrane anchoring and is considered essential for the subcellular targeting and activation of RHO family proteins (4, 5) . For example, when the geranylgeranyl cysteine residue of RAC1 is clipped off by the bacterial YopT protease or when the cysteine in its CAAX motif is mutated to serine, RAC1 localizes to the nucleus (6) (7) (8) . Geranylgeranylation may also be important for protein-protein interactions, such as the binding of RHO proteins to RHO GTPase activating proteins (RHO-GAPs), which stimulate GTP hydrolysis and inactivation; RHO guanine nucleotide exchange factors (RHO-GEFs), which stimulate GDP/GTP exchange and activation; and RHO guanine-nucleotide dissociation inhibitor (RHO-GDI), which sequesters the GDP-bound inactive form of RHO proteins in the cytosol (8) (9) (10) (11) . Thus, inhibiting the geranylgeranylation of RHO family proteins might interfere with their targeting to membranes and their function.
GGTase-I inhibitors (GGTIs) were developed as anticancer drugs primarily because several RHO family members contribute to tumor growth and metastasis (12) . GGTase-I was validated as a drug target with genetic strategies in mice (13) , and one GGTI is being evaluated in a phase I clinical trial. But the activities of RHO family proteins are also important for the ability of macrophages and lymphocytes to migrate into tissues, respond to inflammatory stimuli, and trigger ROS production, phagocytosis, NF-κB signaling, and cytokine production (2) . Consequently, inhibiting GGTase-I has been viewed as a potential strategy to inhibit the proinflammatory activities of RHO family proteins and to treat inflammatory and autoimmune diseases such as rheumatoid arthritis (14, 15) .
Inhibiting the geranylgeranylation of RHO family proteins has also been proposed to explain the antiinflammatory properties and other pleiotropic effects of statins (16, 17) . These widely used cholesterol-lowering drugs may be beneficial in the treatment of rheumatoid arthritis and autoimmune diseases (17) (18) (19) (20) . Statins lower cholesterol levels by blocking the production of mevalonate, which reduces the levels of geranylgeranyl pyrophosphate, the lipid substrate for GGTase-I, and, to a lesser extent, the levels of farnesyl pyrophosphate, the lipid substrate for FTase (21) .
Thus, several lines of investigation suggest that inhibiting protein geranylgeranylation might be a strategy to treat inflammatory diseases, but to our knowledge, the effects of inhibiting GGTase-I have not been convincingly assessed in mouse models of inflammation. To address this issue, we bred conditional GGTase-I knockout mice with mice expressing Cre recombinase in macrophages, with the goal of defining how GGTase-I deficiency affects macrophage function in vitro and the development of inflammatory diseases in vivo. Surprisingly, GGTase-I deficiency did not impair macrophage migration or phagocytosis and resulted in accumulation of GTP-bound RAC1, increased production of ROS and proinflammatory cytokines, and progressive erosive arthritis.
Results
Inactivating GGTase-I in macrophages induces spontaneous erosive arthritis in mice. To produce mice lacking GGTase-I in macrophages, we used a conditional GGTase-I knockout allele (Pggt1b fl ) and a lysozyme M-Cre allele (LC) (13) . The extent of Cre recombination of Pggt1b in BM-derived macrophages was greater than 90%, as judged by quantitative PCR (QPCR) of genomic DNA ( Figure 1A ), which suggests that the majority of macrophages lacked both copies of Pggt1b. Similarly, recombination in osteoclasts was 84%. In neutrophils, the extent of recombination of Pggt1b was 40%; recombination in dendritic cells and lymphocytes was low ( Figure 1A ). Pggt1b fl/fl LC mice are born at Mendelian ratios and have no obvious phenotypes; the red and white blood cell counts and the percentages of monocytes, neutrophils, and lymphocytes in peripheral blood are unaffected (13) .
Histological analyses of joints of 8-to 17-week-old Pggt1b fl/fl LC mice revealed severe inflammation characterized by accumulation of leukocytes, proliferation of synovial tissue (synovitis), and bone erosions ( Figure 1 , B and C). The lesions were most pronounced in metatarsal and metacarpal joints but were also found in the ankle, wrist, knee, and elbow. Synovitis was mild, and no bone erosions were identified, in joints of 3-week-old Pggt1b fl/fl LC mice (data not shown). The disease phenotypes were similar in Pggt1b fl/fl LC mice maintained on mixed (129Sv/Ola-C57BL/6) and 5-generation inbred (C57BL/6) genetic backgrounds. Littermate Pggt1b fl/+ LC and wild-type control mice had normal joint histology, typically with a single-cell-layer synovium (Figure 1 , B and C). Bone erosions in Pggt1b fl/fl LC mice were visible on microcomputerized tomography scans of the knee, but the mineral density of trabecular and cortical bone and the cortical thickness of femur and tibia were not different in Pggt1b fl/fl LC and Pggt1b fl/+ LC mice (Supplemental Figure 1 , A-D; supplemental material available online with this article; doi:10.1172/JCI43758DS1). The Pggt1b fl/fl LC mice had no histological evidence of inflammation in lung, liver, or kidneys (Supplemental Figure 1E ).
To determine whether FTase deficiency in macrophages induces joint inflammation, we used a conditional allele for the FTase β subunit (Fntb fl ) (22) to produce Fntb fl/fl LC mice. At 33 weeks of age, Fntb fl/fl LC mice had no signs of inflammation and were indistinguishable from Fntb fl/+ LC and wild-type controls ( Figure 1B) . Moreover, simultaneous inactivation of FTase and GGTase-I (i.e., in Pggt1b fl/fl Fntb fl/fl LC mice) resulted in phenotypes similar to those after inactivation of GGTase-I alone ( Figure 1B) .
The arthritis in Pggt1b fl/fl LC mice is mediated by macrophages. Immunohistochemical analysis of the thickened synovial lining in joints of Pggt1b fl/fl LC mice revealed widespread staining of F4/80 (a marker of mature macrophages) and nonprenylated RAP1A (np-RAP1A; a marker of cells lacking GGTase-I) (22) and moderate staining of the T lymphocyte marker CD4 ( Figure 1D ). The specificity of the np-RAP1A antibody is illustrated in Supplemental Figure 1F .
To determine whether macrophages are a driving force in arthritis development, we injected 4-week-old Pggt1b fl/fl LC mice with etoposide, which reduces levels of circulating monocytes by greater than 90% and has little effect on granulocytes and lym-phocytes (23, 24) . After 8 weeks of treatment, the mean synovitis score was reduced by 72%, and the mean bone erosion score was reduced by 35% ( Figure 1E ).
To assess inflammatory responses, Pggt1b fl/fl LC and Pggt1b fl/+ LC mice were challenged with an olive oil injection in the hind paw to induce neutrophil-dependent inflammation or with an oxazoloneinduced delayed-type hypersensitivity reaction to induce T lymphocyte-dependent inflammation. The responses of Pggt1b fl/fl LC and Pggt1b fl/+ LC mice did not differ significantly (Supplemental Figure 1 , G and H), consistent with the low level of Pggt1b knockout in those cell types ( Figure 1A ).
Evaluation of humoral responses revealed higher serum levels of autoantibodies recognizing citrullinated peptides (CCP), Fc chain of Igs (rheumatoid factor [RF]), and single-stranded DNA (ssDNA) in Pggt1b fl/fl LC mice than in Pggt1b fl/+ LC mice ( Figure 1F ), which suggests that B lymphocytes are secondarily affected by GGTase-I deficiency in macrophages.
The erosive arthritis of Pggt1b fl/fl LC mice is transplantable and reversible. To rule out mosaic expression of Cre in non-BM cell types as a cause of arthritis in Pggt1b fl/fl LC mice, we performed BM transplantation experiments. Pggt1b fl/fl LC BM cells stably repopulated lethally irradiated wild-type recipient mice and induced mild synovitis at 8 weeks and robust synovitis with bone erosions at 14 weeks after transplantation ( Figure 1G and Supplemental Figure 2A ). After transplantation of wild-type BM cells in 12-week-old Pggt1b fl/fl LC mice, which invariably had severe disease phenotypes, joint inflammation and bone erosions were reduced at 8 weeks and largely eliminated at 14 weeks ( Figure 1H and Supplemental Figure 2A ). The improved arthritis phenotypes were likely not a result of irradiation per se, as lethally irradiated Pggt1b fl/fl LC recipients of Pggt1b fl/fl LC BM cells had levels of inflammation and erosion similar to those in untransplanted controls (Supplemental Figure 2B) .
GGTase-I-deficient macrophages are small and rounded, but migration and phagocytosis are unaffected. We harvested BM cells from Pggt1b fl/fl LC and Pggt1b fl/+ LC mice and differentiated them into macrophages in medium containing M-CSF. Pggt1b fl/fl LC and Pggt1b fl/+ LC macrophages expressed similar levels of macrophage cell surface markers, as judged by fluorescence-activated cell sorting (FACS; Figure 2A ). np-RAP1A accumulated in Pggt1b fl/fl LC BM macrophages and in Pggt1b fl/+ LC BM macrophages incubated with a GGTI, as judged by Western blot of total cell lysates; np-RAP1A levels were low in Pggt1b fl/fl LC BM macrophages incubated with a lentivirus expressing human PGGT1B (lenti-PGGT1B) and undetectable in Pggt1b fl/+ LC BM macrophages ( Figure 2B ).
Pggt1b fl/fl LC BM macrophages were small and rounded, with an average cell adhesive area approximately 80% smaller than in Figure 3C ). GTP-bound CDC42 and RHOA also accumulated in Pggt1b fl/fl LC macrophages ( Figure 3 , B and C). Total levels of RAC1 and CDC42 were similar in Pggt1b fl/fl LC and Pggt1b fl/+ LC cells; total levels of RHOA were slightly increased ( Figure 3 , A-C).
From previous studies, we suspected that nonprenylated RAC1 would accumulate in the nucleus (6) (7) (8) . This suspicion was not upheld. Western blots of subcellular fractions of Pggt1b fl/fl LC macrophages revealed RAC1 in the membrane and cytosolic fractions, as in Pggt1b fl/+ LC macrophages, which had trace amounts of nuclear RAC1 ( Figure 3D ). RHOA and CDC42 were mainly cytosolic in both Pggt1b fl/fl LC and Pggt1b fl/+ LC macrophages, although the latter cells had trace amounts in the membrane fraction ( Figure 3D ).
In Pggt1b fl/+ LC macrophages, RAC1 was associated with the endoplasmic reticulum and the plasma membrane, including clear staining at membrane ruffles and filopodia, as shown by immunofluorescence confocal microscopy ( Figure 3E ). RAC1 immunostaining was reduced by treatment with a RAC1 shRNA lentivirus, but not a RAC2 shRNA lentivirus, demonstrating the specificity of the antibody (Supplemental Figure 3D ). In Pggt1b fl/fl LC macrophages, RAC1 staining was observed at perinuclear struc-tures, was clearly localized at the plasma membrane, and overlapped considerably with staining of the plasma membrane protein Na/K-ATPase ( Figure 3E ). Incubating Pggt1b fl/fl LC and Pggt1b fl/+ LC macrophages with an FTI and a GGTI did not affect RAC1 plasma membrane localization (Supplemental Figure 3E ).
Immunoprecipitation and Western blot analyses revealed less association of RHO-GDI with RAC1 and CDC42 in Pggt1b fl/fl LC than in Pggt1b fl/+ LC macrophages ( Figure 3F ). The association of RHO-GDI with RHOA was unaffected by GGTase-I deficiency ( Figure 3F ).
RHO family proteins accumulate in unprocessed form in GGTase-Ideficient macrophages. To determine whether GGTase-I substrates accumulate in unprocessed form in GGTase-I-deficient macrophages, we incubated whole-cell lysates of Pggt1b fl/fl LC and Pggt1b fl/+ LC macrophages with 3 H-GGPP and recombinant human GGTase-I. In this assay, 3 H-GGPP was readily incorporated into unprocessed substrates by recombinant GGTase-I in vitro; total proteins or RAC1 and RHOA immunoprecipitated from the reaction mixture were resolved by SDS-PAGE and visualized by autoradiography. As expected, no 3 H-GGPP was incorporated into proteins in Pggt1b fl/+ LC extracts ( Figure 3G ), which indicated that all GGTase-I substrates had already been prenylated by endogenous GGTase-I. In contrast, there was robust incorporation of 3 H-GGPP into total proteins, RAC1, and RHOA in Pggt1b fl/fl LC extracts ( Figure 3G ). Thus, RHO family proteins accumulate in unprocessed form in Pggt1b fl/fl LC cells.
Knockout of GGTase-I activates proinflammatory signaling pathways. Next, we determined whether RAC1-GTP accumulation in GGTase-I-deficient macrophages increases ROS production and other pathways downstream of RAC1. First, we stimulated the cells with PMA. ROS production was greater in Pggt1b fl/fl LC than in Pggt1b fl/+ LC macrophages ( Figure 4A ). Second, we performed Western blots on lysates of Pggt1b fl/fl LC and Pggt1b fl/+ LC macrophages before and after LPS stimulation. LPS-stimulated phosphorylation of p38 was increased in Pggt1b fl/fl LC macrophages ( Figure 4B ). Finally, LPS-induced phosphorylation and DNA-binding activity of the NF-κB p65 subunit were higher in Pggt1b fl/fl LC macrophages ( Figure 4 , C and D).
Consistent with increased NF-κB activation, expression of Csf2, Tnfa, Il1b, Il6, and 8 other NF-κB-regulated genes was higher, and expression of 3 such genes was lower, in LPS-stimulated Pggt1b fl/fl LC than in Pggt1b fl/+ LC BM macrophages ( Figure 4E , Supplemental Figure 4A , and Supplemental Table 1 ). Expression of Adamts1, fibronectin (Fn1), Mmp3, Mmp12, and genes encoding 4 other extracellular matrix-associated proteins was also increased ( Figure 4F and Supplemental Table 2 ). Similar gene expression changes were observed in i.p. macrophages (Supplemental Figure 4B) . Moreover, the medium of LPS-stimulated Pggt1b fl/fl LC macrophages contained higher concentrations of TNF-α, IL-1β, and IL-6 ( Figure 4G ) as well as interferon-γ, IL-10, IL-12p70, and KC (data not shown). We also observed increased secretion of cytokines in Pggt1b fl/+ LC macrophages incubated with a GGTI before and during LPS stimulation ( Figure 4G ).
Inhibiting RAC1 reduces cytokine production of macrophages in vitro, and TNF-α inhibition reduces joint inflammation in vivo. To assess the role of RAC1 in the increased cytokine production of Pggt1b fl/fl LC BM macrophages, we incubated the cells with lentiviral constructs before and during LPS stimulation and measured IL-1β levels in the medium. As expected, IL-1β levels were reduced by lenti-PGGT1B but were unaffected by expression of fRAC1 or fRHOA; IL-1β levels were also markedly reduced by knockdown of RAC1 with a RAC1 shRNA lentivirus but were unaffected by RAC2 or sequence-scrambled shRNA ( Figure 5A ). The shRNAs reduced expression by 60%-90%, as determined by semiquantitative RT-PCR ( Figure 5B) and TaqMan RT-QPCR (data not shown). IL-1β and TNF-α levels were reduced in a dose-dependent fashion in the medium of Pggt1b fl/fl LC macrophages incubated with a RAC1 inhibitor and an inhibitor of the RAC1 downstream effector PAK ( Figure 5, C and D) . Thus, the high levels of RAC1-GTP in GGTase-I-deficient macrophages likely caused the increased IL-1β and TNF-α production. TNF-α is a well-known drug target in the treatment of rheumatoid arthritis. To determine whether TNF-α might be important for the disease phenotypes in vivo, we treated 12-week-old Pggt1b fl/fl LC mice with the TNF-α receptor analog Enbrel (etanercept; Wyeth Pharmaceuticals) for 8 weeks. Synovitis was reduced by 41%; bone erosions were unaffected ( Figure 5E ).
Discussion
In this study, we tested the hypothesis that inactivating GGTase-I would reduce the development of inflammatory disorders in mice. Contrary to our expectations, inactivating GGTase-I in macrophages resulted in sustained activation of RHO proteins, increased the production of ROS and cytokines, and induced a severe inflam- matory joint disease in vivo. The disease was chronic, progressive, and associated with synovitis, bone erosions, and increased serum levels of autoantibodies -phenotypes resembling rheumatoid arthritis in humans. The arthritis in Pggt1b fl/fl LC mice was similar in outbred and inbred genetic strains, and synovitis and bone erosions were reversible in BM transplantation experiments.
Macrophages are important in the pathogenesis of rheumatoid arthritis (25) (26) (27) . However, they are primarily viewed as effector cells that contribute to the progression rather than the initiation of rheumatoid arthritis (28, 29) . Our results challenge that view and suggest that macrophages can initiate erosive arthritis in Pggt1b fl/fl LC mice. First, the LC allele induced greater than 90% recombination of Pggt1b in macrophages, but only 40% in neutrophils, and little or no recombination in dendritic cells and lymphocytes. Second, GGTase-I-deficient macrophages were found at high levels in the synovium of Pggt1b fl/fl LC mice. Third, GGTase-I-deficient macrophages showed exaggerated responses to inflammatory mediators in vitro. Fourth, monocyte depletion with etoposide reduced arthritis in Pggt1b fl/fl LC mice. Cre recombination was also high in osteoclasts. However, we believe it unlikely that osteoclasts initiated the arthritis because infiltration of GGTase-I-deficient macrophages invariably preceded bone erosions in the joints, and overall bone health was unaffected.
Joint inflammation was reduced by Enbrel treatment, indicating that TNF-α drives arthritis in Pggt1b fl/fl LC mice. GGTase-Ideficient macrophages secreted high levels of TNF-α in vitro, and macrophages are believed to be the main source of this cytokine in vivo (30) . However, we cannot rule out the possibility that the action of TNF-α derived from other cell types, such as lymphocytes, is affected by Enbrel treatment. Enbrel treatment did not affect bone erosions, which suggests that TNF-α explains only part of the phenotype.
GGTase-I-deficient macrophages in culture had a reduced adhesive area, consistent with a role for RHO family proteins in regulating the cytoskeleton (2). The adhesive area was readily restored by expressing fRHOA or fRAC1. Thus, prenylation of RHOA and RAC1 appears to be required for their ability to regulate the spreading of macrophages in culture. Surprisingly, the absence of GGTase-I did not affect the ability of macrophages to migrate or phagocytose bacteria, which suggests that geranylgeranylation is dispensable for those processes.
GTP-bound forms of RAC1 and CDC42 were present at high levels in GGTase-I-deficient macrophages without corresponding increases in total protein levels. One potential explanation is that geranylgeranylation may be required for the binding of RHO family proteins to RHO-GAPs. In support of this reasoning, one study showed that RHO-GAPs cannot stimulate GTP hydrolysis of nonprenylated RHO proteins (10) . Another potential explanation is that geranylgeranylation stimulates the interaction between RHO family proteins and RHO-GDI (4, 31, 32) . Indeed, the association between RHO-GDI and RAC1 and between RHO-GDI and CDC42 was reduced in GGTase-I-deficient macrophages. In contrast, the association between RHO-GDI and RHOA was not affected by GGTase-I deficiency, which is consistent with previous studies (33, 34) and may explain the relatively low level of accumulation of GTP-bound RHOA compared with RAC1 and CDC42. A recent study provided a different perspective on the importance of RHO protein geranylgeranylation and the RHO-GDI interaction (35) . Knockdown of RHO-GDI resulted in degradation of RHOA, RAC1, and CDC42. Interestingly, degradation only occurred if the proteins were geranylgeranylated. Thus, when RHO-GDI levels are limiting, the geranylgeranyl lipid targets the RHO proteins for degradation.
A substantial proportion of RAC1 in GGTase-I-deficient macrophages was localized at the plasma membrane; we found no evidence of nuclear localization. In contrast, several studies show that nonprenylated RAC1 is localized in the nucleus (6, 7, 32) . These divergent results may relate to the use of different cell types and antibodies and to the fluorescent tags used to determine the subcellular localization of RAC1 in earlier studies. We used a specific antibody to locate endogenous RAC1 in GGTase-I-deficient macrophages by immunohistochemistry; the results were consistent with Western blots of subcellular fractions. RAC1 has a strong polybasic sequence (8) , and electrostatic interactions may be sufficient for plasma membrane targeting.
Interestingly, trace amounts of RAC1 were present in the nuclear fraction of control Pggt1b fl/+ LC macrophages. This finding is consistent with a report of endogenous prenylated RAC1 in the nucleus of several cell types (32) . Because no RAC1 was identified in the nuclei of Pggt1b fl/fl LC macrophages, geranylgeranylation may be required for RAC1 nuclear import.
The observations that Pggt1b fl/fl LC macrophages exhibited normal migration and phagocytosis and that RAC1 was found on the plasma membrane raise the question of whether GGTase-I substrates might be processed by FTase, residual GGTase-I activity, or RAB protein prenyltransferase GGTase-II. However, several results argue against that reasoning. First, GGTase-I substrates, including RAC1 and RHOA, accumulated in unprocessed form in Pggt1b fl/fl LC macrophages. Second, RAC1 in Pggt1b fl/fl LC macrophages exhibited reduced electrophoretic mobility. Third, RAC1 remained associated with the plasma membrane in GGTase-I-deficient macrophages incubated with an FTI and a GGTI.
The plasma membrane location and increased levels of RAC1-GTP can explain the LPS-induced increase in cytokine production by GGTase-I-deficient macrophages. IL-1β and TNF-α levels were reduced in cells treated with a RAC1 shRNA lentivirus and with inhibitors of RAC1 and PAK. Interestingly, increased IL-1β secretion was observed in earlier studies, in which protein prenylation was reduced indirectly by a deficiency in mevalonate kinase or by statin treatment (36) (37) (38) . However, the reduced isoprenoid synthesis in those studies likely affected both the farnesylation and the geranylgeranylation of CAAX proteins, as well as the geranylgeranylation of the RAB family proteins, which are prenylated by an unrelated enzyme, GGTase-II (39) . Our results provide a firm link between nonprenylated RAC1 and increased cytokine production in macrophages.
In summary, inactivating GGTase-I in macrophages resulted in sustained activation of RHO family proteins and spontaneous erosive arthritis in mice. The results challenge the view that geranylgeranylation is essential for the activity and membrane targeting of RAC1 and other RHO family proteins, suggesting that one role of protein geranylgeranylation is to inhibit, rather than stimulate, their activity.
Methods
Gene-targeted mice, genotyping, and quantification of Cre recombination. Mice homozygous for a conditional knockout allele of the β subunit of GGTase-I and heterozygous for the lysozyme M-Cre knockin allele (Pggt1b fl/fl LC) have been described previously (13) . Controls were littermate Pggt1b fl/+ LC mice; additional controls were littermate Pggt1b +/+ LC, Pggt1b fl/+ , and Pggt1b fl/fl mice, collectively called wild-type. Genotyping and quantification of Cre recombination were done as described previously (13) . Mice harboring Fntb fl , a conditional knockout allele for the β subunit of FTase, were recently created (22) . Mice were on a mixed genetic background (129Ola/ Hsd-C57BL/6) or backcrossed 5 times onto a pure C57BL/6 background. Mouse experiments were approved by the University of Gothenburg Animal Research Ethics Committee.
Generation of BM-derived and peritoneal macrophages. BM cells were harvested from femur and tibia and plated in high-glucose DMEM supplemented with 10% fetal calf serum, 1% HEPES, 1% glutamine, 1% gentamicin, 0.01% β-mercaptoethanol, and 10% whole supernatant of cell line CMG14-12 as a source of mouse M-CSF (40) . Experiments were performed on differentiated macrophages on days 7-10 after plating. i.p. macrophages were collected 4 days after an i.p. injection of 2 ml of 3% uric acid (41) . Experiments were performed on days 1-3 after plating. Experiments were performed at least twice with macrophages prepared on different days.
Generation of osteoclasts and isolation of myeloid subsets and lymphocytes. Osteoclasts were generated by incubating BM-derived macrophages with 40 ng/ml recombinant RANK ligand (Invitrogen) for 5 days as described previously (42) ; identity of osteoclasts was confirmed by staining for tartrate-resistant acid phosphatase (TRAP Staining Kit, Sigma-Aldrich). Dendritic cells were isolated from spleens with the Dendritic Cell Enrichment Kit (Invitrogen). Neutrophils were isolated from peripheral blood as described previously (43) . CD3 + lymphocytes were isolated from spleens by FACS sorting.
Histology and immunohistochemistry. For routine histology, joints were decalcified in Parengy buffer and fixed in 4% paraformaldehyde, embedded in paraffin, sectioned, and stained with hematoxylin and eosin. For immunohistochemistry, joints were decalcified in 0.1 M Tris-EDTA buffer and frozen in OCT (Sakura Finetek). Cryosections were incubated with antibodies recognizing F4/80 (catalog no. MCA-497, Serotec), np-RAP1A (catalog no. sc-1482, Santa Cruz Biotechnology), and CD4 (catalog no. 550280, BD Biosciences -Pharmingen) overnight at 4°C and with biotinylated anti-goat or anti-rat secondary antibodies (Vector Laboratories) for 1 h at room temperature. The slides were then incubated with StreptABComplxes (Dako) and hydrogen peroxide and counterstained with Mayer hematoxylin. Slides were analyzed with a Zeiss Axioplan 2 microscope (Carl Zeiss AG).
Quantifying inflammation and bone erosion in mouse joints. Synovitis and bone erosion were evaluated in the knee, ankle, metatarsal, elbow, wrist, and metacarpal joints of mice by an observer blinded to genotype. Synovitis was defined as a synovial membrane thickness of more than 2 cell layers. Synovitis and subchondral bone erosion in each joint were individually scored as 1 (mild), 2 (moderate), or 3 (severe), and the scores were added to produce total inflammation and erosion scores for each mouse (44) .
Etoposide and Enbrel treatment. For monocyte depletion, etoposide (10 mg/kg; Bristol-Myers Squibb) was injected subcutaneously in 4-weekold mice every second day for 8 weeks (24) . To inhibit TNF-α signaling in vivo, Enbrel (TNF-α receptor analog; 100 mg/kg/week; Wyeth Pharmaceuticals) was injected i.p. in 6-to 8-week-old mice every second day for 8 weeks (45) . Littermate controls were injected with PBS.
Measurement of serum antibodies. Antibodies recognizing CCP, Fc-IgG (RF), ssDNA, and collagen type II were measured in serum from 12-week-old mice as described previously (46) (47) (48) .
BM transplantation. BM cells were harvested from femur and tibia of donor mice. Recipient mice were given neomycin and polymyxin-B in the drinking water for 7 days (to prevent radiation damage-induced infections) before and after a lethal dose of radiation (950 Gy). The day after irradiation, mice were injected with 10 7 unfractionated donor cells in 200 μl RPMI-1640 as described previously (49) . Engraftment was confirmed by genotyping genomic DNA from peripheral blood of the recipient mice.
FACS analyses. BM macrophages were incubated with antibodies recognizing CD45 (catalog no. 557659), CD11b (catalog no. 550993), CD11c (catalog no. 550261), MAC3 (catalog no. 553324), Gr-1 (catalog no. 553129, BD Biosciences), MAC2 (catalog no. 8942F; Cederlane), and F4/80 (catalog no. MCA497APC; Serotec) and analyzed in a FACSAria Flow Cytometer (BD Biosciences). Data were analyzed with FACSDiva software (version 6.1.1; BD Biosciences). Apoptosis was detected with the Annexin V:EGFP Apoptosis Detection Kit (Biovision).
Immunoprecipitation, subcellular fractionation, and Western blotting. Total cellular lysates were isolated as described previously (50) . GTP-bound RAC1 and CDC42 were affinity precipitated with PAK1-GST (EZ Detect Rac1 Activation Kit; Pierce), and GTP-bound RHOA was affinity precipitated with RHOTEKIN-GST (RhoA Activation Biochem Kit; Cytoskeleton). Immunoprecipitation of RHO-GDI was performed with a monoclonal antibody (catalog no. sc-360, Santa Cruz Biotechnology) and the Dynabeads Protein G immunoprecipitation kit (catalog no. 100-07D, Invitrogen). For analyses of p38 activation, lysates were prepared from BM macrophages before and 15 minutes after stimulation with LPS (10 ng/ml); for NF-κB activation, lysates were isolated before and 15 and 30 minutes after stimulation. Isolation of subcellular fractions was done with the Qproteome Cell Compartment Kit (Qiagen). Protein samples were run on 10%-20%, 12%, or 18% SDS-PAGE gels (Criterion, Protean, BioRad), transferred to nitrocellulose or PVDF membranes, and incubated with antibodies to RAC1 (catalog no. 05-389, Millipore; and antibody supplied in RAC1 activation kit, Pierce), RHOA (catalog no. ARH03-B, Cytoskeleton), CDC42 (catalog no. sc-2462), np-RAP1A (catalog no. sc-1482), RHO-GDIα (catalog no. sc-360), lamin A/C (catalog no. sc-7293, Santa Cruz Biotechnology), β1-integrin (catalog no. 4706), phospho-p38 (catalog no. 9211), total p38 (catalog no. 9212), phospho-p65 Ser536 (catalog no. 3031, Cell Signaling), FLAG-tag (catalog no. F3165, Sigma-Aldrich), MYC-tag (catalog no. R950-25, Invitrogen), and actin (catalog no. A2066, Sigma-Aldrich). Prelamin A antibody was provided by S.G. Young and L.G. Fong (UCLA, Los Angeles, California, USA). Protein bands were visualized with horseradish peroxidase-conjugated secondary antibodies (catalog no. sc-2354, Santa Cruz Biotechnology; catalog nos. NA931 and NA934, GE Healthcare) and the ECL Western blotting system (GE Healthcare). Protein bands were analyzed by densitometry with Quantity One (version 4.4.0; Bio-Rad).
Phalloidin staining and immunocytochemistry. Macrophages on chamber slides were fixed with 4% paraformaldehyde for 15 minutes, permeabilized in 0.1 % Triton X-100 for 5 minutes, and stained with Alexa Fluor 647-labeled phalloidin (catalog no. A22287, Invitrogen) for 20 minutes. For immunocytochemistry, macrophages were fixed with ice-cold methanol, permeabilized in 1.0% Triton X-100 for 15 minutes, and incubated with antibodies recognizing RAC1 (catalog no. ARC03, Cytoskeleton) and Na/K-ATPase-α (catalog no. 28800, Santa Cruz Biotechnology) overnight at 4°C. The slides were then incubated with Alexa Fluor 488-and 547-labeled secondary antibodies (catalog nos. A11001 and A10040, respectively, Invitrogen) for 1 hour, mounted with Prolong Antifade with DAPI (catalog no. P36935, Invitrogen), and analyzed with a Leica TCS SP5 confocal microscope and LAS Advanced Fluorescence software (version 2.0.2, Leica Microsystems).
Lentivirus experiments. A FLAG-tagged fRAC1 construct (RAC1-CVLS) was generated by PCR amplification of mouse cDNA with forward primer 5′-AGGATCCGAAATGGACTACAAGGACGACGATGACAAGATGCAG-GCCATCAAGTGTGTGGTGG-3′ and reverse primer 5′-AGGATCCT-TACGAGAGCACGCATTTTCTCTTCCTCTTC-3′. A MYC-tagged fRHOA construct (RHOA-CVLS) was generated as described previously (13) . The human PGGT1B cDNA clone was from Imagenes (catalog no. EX-C0587). fRAC1, fRHOA, and PGGT1B constructs were cloned into lentiviral vector pCD521A-1_pCHD-EF1dTomato-T2A (catalog no. CD520A-1, Biocat). Lentiviruses expressing RAC1 and RAC2 shRNA were from
